ROBERT FELL: Open Payments
NPI 1396908067 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 31 payments from 10 companies in 2025. Trend: 2023 $747 · 2024 $1,258 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $231 |
| SHIELD THERAPEUTICS INC | 5 | $220 |
| Medtronic, Inc. | 1 | $147 |
| Novo Nordisk Inc | 6 | $114 |
| Amgen Inc. | 4 | $62 |
| Lilly USA, LLC | 3 | $58 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: ACCRUFER, QULIPTA, INTERSTIM, Ozempic, UBRELVY, EVENITY, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across VA — which companies pay providers there.
